Sedation with propofol and remifentanil for real-time endobronchial ultrasound needle aspiration

Vilà, Esther; Mases, A.; Vela, Enrique; Moltó, L.; Sánchez-Font, Albert; Curull, Víctor; Gallart, L.

doi:10.1016/j.rcae.2013.01.005

Cited by 6 publications

(7 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 12 ] Vila et al ., in a study using conventional doses of remifentanil (up to 0.17 μg/kg/min) with propofol based TIVA, found that coughing incidence was as high as 81%. [ 13 ] In our practice, the incidence of coughing was almost half that found by Vila et al . which again is related possibly to the higher dose of remifentanil used.…”

Section: Discussionmentioning

confidence: 55%

Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures

et al. 2014

View full text Add to dashboard Cite

BACKGROUND:Anesthesia for bronchoscopy presents unique challenges, as constant stimulus due to bronchoscope needs to be obtunded using drugs with a minimal post-procedure residual effect. Remifentanil for maintenance is an ideal choice, but optimal doses are yet to be determined.MATERIALS AND METHODS:Bronchoscopic procedures were prospectively evaluated for 4 months studying the frequency of complications and anesthesia techniques. Anesthesia was maintained on remifentanil/propofol infusion avoiding neuromuscular blockers. Laryngeal mask airway was used for the controlled ventilation (with high oxygen concentration) that also served as a conduit for bronchoscope insertions. Anesthesiologists were blinded to the study (avoiding performance bias) and the Pulmonologist was blinded to the anesthesia technique (to document unbiased procedural satisfaction scores). Procedures were divided into 2 groups based on the dose of remifentanil used for maintenance: Group-H (high dose −0.26 to 0.5 μg/kg/min and Group-NH (non-high dose ≤0.25 μg/kg/min).RESULTS:Observed 75 procedures were divided into Group-H (42) and Group-NH (33). Number of statistical difference was found in demography, procedural profile, hemodynamic parameters and total phenylephrine used. Chi-square test showed Group-NH had significantly higher frequency of laryngospasm (P = 0.047) and coughing (P = 0.002). The likelihood ratio of patient coughing and developing laryngospasm in Group-NH was found to be 4.56 and 10.97 times respectively. Minimum pulse-oximeter saturation was statistically higher in Group-H (98.80% vs. 96.50% P = 0.009). Pulmonologist satisfaction scores were significantly better in Group-H.CONCLUSIONS:High dose of remifentanil infusion is associated with a lower incidence of coughing and laryngospasms during bronchoscopy. Simultaneously, it improves Pulmonologist's satisfaction and procedural conditions.

show abstract

Section: Discussionmentioning

confidence: 55%

Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures

et al. 2014

View full text Add to dashboard Cite

show abstract

“…compared procedure duration and hospital‐stay between moderate and deep sedation during EBUS‐TBNA procedure and found that procedure duration was shorter in deep sedation with continuous propofol infusion group than the moderate sedation with fentanyl and midazolam group; however, the difference was not statistically significant. Hospital‐stay was significantly shorter in moderate sedation group . Casal et al .…”

Section: Discussionmentioning

confidence: 91%

“…major complications are reported. Two cases of arrhythmias requiring electrical cardioversion and cardiac compressions were reported in the study comparing sedation with propofol and remifentanil . Minor complications such as temporary desaturation, hypotension, self‐restricting bleeding occurred frequently.…”

Section: Discussionmentioning

confidence: 99%

A comparison of propofol–midazolam and midazolam alone for sedation in endobronchial ultrasound‐guided transbronchial needle aspiration: a retrospective cohort study

Oztas

Aktürk

Alpay

et al. 2016

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

“…Sedation is therefore strongly recommended in order to reduce the stress reaction, enhance patient cooperation, diminish the levels of anxiety and fear, provide amnesia and prevent coughing during the intervention [8]. For therapeutic bronchoscopic procedures, such as prolonged laser therapy, endobronchial sonography, stent implantation (usually with rigid instruments), embedded foreign body as in our case, general anaesthesia is necessary [9]. General anaesthesia is also necessary in children, restless or agitated adults.…”

Section: Discussionmentioning

confidence: 98%

Nasopharyngeal Airway As A Supraglottic Ventilation Device For Bronchoscopic Interventions

Kanaparthi¹,

Nair²,

Kale³

et al. 2019

JACCR

View full text Add to dashboard Cite

Introduction: Bronchoscopy is performed for diagnostic and therapeutic purposes. It is a challenge for the anaesthesiologist to maintain ventilation for the patient as the patients’ airway is shared between the anaesthetist and the bronchoscopist. Many modalities have been used for anaesthesia and airway management for bronchoscopies. We present a case of bronchoscopy guided foreign body removal under anaesthesia. Spontaneous ventilation was maintained in the patient with the help of nasal airways. Keywords: Bronchoscopy, Ventilation, Nasal airway.

show abstract

Sedation with propofol and remifentanil for real-time endobronchial ultrasound needle aspiration

Cited by 6 publications

References 28 publications

Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures

Effectiveness of high dose remifentanil in preventing coughing and laryngospasm in non-paralyzed patients for advanced bronchoscopic procedures

A comparison of propofol–midazolam and midazolam alone for sedation in endobronchial ultrasound‐guided transbronchial needle aspiration: a retrospective cohort study

Nasopharyngeal Airway As A Supraglottic Ventilation Device For Bronchoscopic Interventions

Contact Info

Product

Resources

About